Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth RestrictionCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Death, Female Urogenital Diseases and Pregnancy Complications, Fetal Death, Fetal Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, fetal growth restriction, hereditary endocrine growth disease, pregnancy disorder, pregnancy disorder with abortive outcomeRecruitingPhase 32025-06-06NCT05651347

4 results · Page 1 of 1

Swipe the table sideways for more columns.

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Auckland HospitalAucklandNew Zealand2
Gold Coast University HospitalSouthportAustralia35
Joan Kirner HospitalSaint AlbansAustralia1
John Hunter HospitalNewcastleAustralia14
Mater MisericordiaeSouth BrisbaneAustralia3
Mercy HospitalHeidelbergAustralia1
Middlemore HospitalAucklandNew Zealand6
Monash HealthClaytonAustralia74
Royal Prince AlfredCamperdownAustralia2
Royal Women's HospitalParkvilleAustralia4
Wellington Regional HospitalWellingtonNew Zealand5
Women's and Children's HospitalNorth AdelaideAustralia13